In this video, NAMS medical director Stephanie Faubion, MD, discusses highlights from her presentation at the organization’s annual meeting on nonhormone therapies currently being ...

Positive results were announced from two phase 3 studies evaluating elinzanetant as a treatment for vasomotor symptoms in postmenopausal women. Elinzanetant is an investigational dual neurokinin-1 ...

OASIS 4 is a double-blind, randomized, placebo-controlled multicenter study to investigate efficacy and safety of elinzanetant for the treatment of vasomotor symptoms caused by adjuvant endocrine ...

References Simon JA, Anderson RA, Ballantyne E, Bolognese J, Caetano C, Joffe H, Kerr M, Panay N, Seitz C, Seymore S, Trower M, Zuurman L, Pawsey S. Efficacy and safety of elinzanetant, a ...